Ondansetron ODT 4 MG tablet 30S
Ended Awarded Last action
- Contract number
- SPE2DR26F1V74
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $21,400
Award facts
- Contract value 100% obligated
- $21,400.44 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $21,400.44 to AmerSourceBergen Drug Corp for the supply of Ondansetron ODT 4 mg tablets (30-count units) on January 16, 2026, with a completion date of January 20, 2026. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's Conshohocken, Pennsylvania facility. The award represents a task order under AmerSourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2031, which serves as the primary vehicle for delivering pharmaceutical products and medical supplies to support military healthcare programs globally.
Ondansetron is a widely used antiemetic medication commonly prescribed in military and veteran healthcare settings to manage nausea and vomiting associated with chemotherapy, radiation therapy, and post-operative recovery. AmerSourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, maintains extensive federal contracting relationships with the Defense Logistics Agency and serves as a critical vendor for military medical supply chains. The company's demonstrated capability to fulfill diverse pharmaceutical procurement requirements through competitive contracting positions it well to support the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems under the DLA's comprehensive pharmaceutical prime vendor framework.
Quick answers
Who was awarded contract SPE2DR26F1V74?
SPE2DR26F1V74 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 16, 2026.
How much is contract SPE2DR26F1V74 worth?
The government has obligated $21,400 on SPE2DR26F1V74.
Is contract SPE2DR26F1V74 an order under another contract?
Yes. SPE2DR26F1V74 is a delivery order under SPE2DR25D2205, an indefinite delivery contract.
Was contract SPE2DR26F1V74 competed?
The extent of competition for SPE2DR26F1V74 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award